“SGRT provides the potential to reduce treatment-related errors which could affect patient outcomes, especially within the realm of hypo-fractionated treatments.”
– Juergen Meyer, University of Washington Medical Center and Department of Radiation Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA, and senior author for the study.
C-RAD offers a full range of SGRT solutions, along with robust training, implementation and vendor integration to help ensure the best possible treatment outcome while maximizing efficiency for the treatment team.
You might also be interested in
In this video, Elizabeth Edwards, C-RAD Clinical Applications Specialist, explains how surface-guided solutions, including Catalyst⁺ HD and Catalyst⁺ LITE, support active motion management across the treatment workflow. She highlights how…
From improving DIBH to enabling novel low-dose treatments, these case stories and webinars offer insights from frontline teams using C-RAD’s SGRT across real-world clinical settings. Supporting Precision, Without Adding Complexity…
Contact us
Contact your local office
We have service support groups the USA, China, Germany, France & Sweden
